{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:05:45Z","timestamp":1764155145082,"version":"3.46.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral antibiotics are a mainstay of treatment for hidradenitis suppurativa (HS) primarily due to their anti-inflammatory and anti-microbial properties. Because antibiotics are frequently prescribed to treat HS, concerns exist regarding antibiotic stewardship. There is a paucity of literature comparing how antibiotic prescribing patterns for HS differ between dermatology and non-dermatology clinicians in the ambulatory setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to compare the antibiotic prescribing patterns of dermatology versus non-dermatology clinicians treating HS in the ambulatory setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilised the National Ambulatory Medical Care Survey (NAMCS) to identify visits for HS patients from 2005 to 2016. We performed multivariate logistic regression analysis to compare the likelihood of prescribing (1) antibiotics and (2) tetracyclines between dermatology and non-dermatology clinicians in the ambulatory setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified a total of 2 424 125 (weighted) HS visits. Approximately 28.0% of visits were conducted by dermatology clinicians, while 72.0% were conducted by non-dermatology clinicians. Antibiotics were prescribed in 51.9% of visits. Tetracyclines were the most commonly prescribed antibiotics among visits with dermatology clinicians (33.4%), while penicillins\/cephalosporins were the most commonly prescribed antibiotic among visits with non-dermatology clinicians (14.9%). Multivariate logistic regression analysis demonstrated no difference in the overall likelihood of prescribing antibiotic therapy between dermatology and non-dermatology clinicians (p = 0.35). However, dermatology clinicians were significantly more likely to prescribe tetracyclines than non-dermatology clinicians (OR 5.48, 95% CI 1.19\u201325.26, p = 0.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, dermatology clinicians were significantly more likely to prescribe tetracyclines than non-dermatology clinicians for HS patient visits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ski2.451","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T04:34:00Z","timestamp":1724819640000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparing Antibiotic Prescribing Patterns for Hidradenitis Suppurativa between Dermatology and Non-Dermatology Ambulatory Providers"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1564-6056","authenticated-orcid":false,"given":"Hannah","family":"Tolson","sequence":"first","affiliation":[{"name":"University of Arizona College of Medicine , Phoenix, Arizona ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Keck School of Medicine of University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca K.","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Georgetown University School of Medicine , Washington, District of Columbia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaviyon","family":"Sadrolashrafi","sequence":"additional","affiliation":[{"name":"Kirk Kerkorian School of Medicine at UNLV , Las Vegas, Nevada ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Guo","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Hao","sequence":"additional","affiliation":[{"name":"Keck School of Medicine of University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bilimoria","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, David Geffen School of Medicine at the University of California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Yee","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, David Geffen School of Medicine at the University of California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, David Geffen School of Medicine at the University of California , Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"issue":"1","key":"2025112605522794300_ski2451-bib-0001","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jdv.15233","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization\u2014systematic review and recommendations from the HS ALLIANCE working group","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2025112605522794300_ski2451-bib-0002","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2025112605522794300_ski2451-bib-0003","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2020.12.089","article-title":"The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: results of a prospective European cohort study","volume":"85","author":"van Straalen","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2025112605522794300_ski2451-bib-0004","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12060978","article-title":"Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues","volume":"12","author":"Molinelli","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"2025112605522794300_ski2451-bib-0005","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jdv.15332","article-title":"Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients","volume":"33","author":"Bettoli","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"journal-title":"NAMCS\/NHAMCS\u2014scope and sample design","year":"2019","key":"2025112605522794300_ski2451-bib-0006"},{"journal-title":"NAMCS\/NHAMCS\u2014about the ambulatory Health Care surveys","year":"2021","key":"2025112605522794300_ski2451-bib-0007"},{"issue":"12","key":"2025112605522794300_ski2451-bib-0008","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/jamadermatol.2022.4610","article-title":"Factors associated with dermatologic follow-up vs emergency department return in patients with hidradenitis suppurativa after an initial emergency department visit","volume":"158","author":"Wang","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2025112605522794300_ski2451-bib-0009","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jamadermatol.2018.4944","article-title":"Trends in oral antibiotic prescription in dermatology, 2008 to 2016","volume":"155","author":"Barbieri","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"9","key":"2025112605522794300_ski2451-bib-0010","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamadermatol.2022.3168","article-title":"Antibiotic stewardship in dermatology-reducing the risk of prolonged antimicrobial resistance in skin","volume":"158","author":"MacGibeny","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2025112605522794300_ski2451-bib-0011","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/bjd.17919","article-title":"Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials","volume":"181","author":"Jemec","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"2025112605522794300_ski2451-bib-0012","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"2025112605522794300_ski2451-bib-0013","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1111\/ijd.16448","article-title":"Perceptions of biologic treatment among hidradenitis suppurativa patients on social media: an analysis of content, engagement, and sentiment","volume":"62","author":"Zagona-Prizio","year":"2023","journal-title":"Int J Dermatol"},{"key":"2025112605522794300_ski2451-bib-0014","doi-asserted-by":"publisher","first-page":"30","DOI":"10.25259\/IJDVL_15_2023","article-title":"Janus-kinase inhibitors in dermatology: a review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease","volume":"90","author":"Huang","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"2025112605522794300_ski2451-bib-0015","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.det.2021.05.010","article-title":"The use of biologics during the COVID-19 pandemic","volume":"39","author":"Jones","year":"2021","journal-title":"Dermatol Clin"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/5\/ski2.451\/60660911\/skinhd_4_5_e451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/5\/ski2.451\/60660911\/skinhd_4_5_e451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:52:33Z","timestamp":1764154353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.451\/7896861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,28]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.451","relation":{},"ISSN":["2690-442X"],"issn-type":[{"type":"electronic","value":"2690-442X"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,8,28]]},"article-number":"ski2.451"}}